Capmatinib for the treatment of non-small cell lung cancer

Vansteenkiste, JF; Van de Kerkhove, C; Wauters, E; Van Mol, P

Vansteenkiste, JF (reprint author), Katholieke Univ Leuven, Resp Oncol Unit Resp Dis, Univ Hosp, Herestr 49, B-3000 Leuven, Belgium.

EXPERT REVIEW OF ANTICANCER THERAPY, 2019; 19 (8): 659

Abstract

Introduction: Activation of the MET pathway through MET amplifications or mutations is present in 3-4% of stage IV non-squamous non-small cell lung ca......

Full Text Link